b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="eid" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2819884/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997\xe2\x80\x932006</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819884/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Emerging Infectious Diseases" /><meta name="citation_title" content="Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997\xe2\x80\x932006" /><meta name="citation_authors" content="Dounia Bitar, Dieter Van Cauteren, Fanny Lanternier, Eric Dannaoui, Didier Che, Francoise Dromer, Jean-Claude Desenclos, Olivier Lortholary" /><meta name="citation_date" content="September 2009" /><meta name="citation_issue" content="9" /><meta name="citation_volume" content="15" /><meta name="citation_firstpage" content="1395" /><meta name="citation_doi" content="10.3201/eid1509.090334" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2819884/?report=abstract" /><meta name="citation_pmid" content="19788806" /><meta name="DC.Title" content="Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997\xe2\x80\x932006" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Centers for Disease Control and Prevention" /><meta name="DC.Contributor" content="Dounia Bitar" /><meta name="DC.Contributor" content="Dieter Van Cauteren" /><meta name="DC.Contributor" content="Fanny Lanternier" /><meta name="DC.Contributor" content="Eric Dannaoui" /><meta name="DC.Contributor" content="Didier Che" /><meta name="DC.Contributor" content="Francoise Dromer" /><meta name="DC.Contributor" content="Jean-Claude Desenclos" /><meta name="DC.Contributor" content="Olivier Lortholary" /><meta name="DC.Date" content="2009 Sep" /><meta name="DC.Identifier" content="10.3201/eid1509.090334" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997\xe2\x80\x932006" /><meta property="og:type" content="article" /><meta property="og:description" content="We analyzed hospital records to provide a population-based estimate of zygomycosis incidence and trends over a 10-year period at a national level in France. Data showed an increasing incidence from 0.7/million in 1997 to 1.2/million in 2006 (p&lt;0.001). ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819884/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-eid.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2819884/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2819884/pdf/09-0334_finalR.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1AEB54E9A342D10000000008960895.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/782/">Emerg Infect Dis</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/184805/">v.15(9); 2009 Sep</a></li><li class="accid">PMC2819884</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-eid.gif" alt="Logo of eid" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,500,75" alt="Emerging Infectious Diseases" title="Emerging Infectious Diseases" href="http://wwwnc.cdc.gov/eid/" ref="reftype=publisher&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Emerg Infect Dis</span>. 2009 Sep; 15(9): 1395\xe2\x80\x931401. </span></div><div>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.3201%2Feid1509.090334" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3201/eid1509.090334</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2819884</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19788806">19788806</a></div></div></div></div><h1 class="content-title">Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997&#x02013;2006</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Bitar%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19788806">Dounia Bitar</a>, <a href="/pubmed/?term=Van%20Cauteren%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19788806">Dieter Van Cauteren</a>, <a href="/pubmed/?term=Lanternier%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19788806">Fanny Lanternier</a>, <a href="/pubmed/?term=Dannaoui%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19788806">Eric Dannaoui</a>, <a href="/pubmed/?term=Che%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19788806">Didier Che</a>, <a href="/pubmed/?term=Dromer%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19788806">Francoise Dromer</a>, <a href="/pubmed/?term=Desenclos%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19788806">Jean-Claude Desenclos</a>, and  <a href="/pubmed/?term=Lortholary%20O%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19788806">Olivier Lortholary</a></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140585427131008_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140585427131008_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140585427131008_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">Institut de Veille Sanitaire, Saint Maurice, France (D. Bitar, D. Van Cauteren, D. Che, J.-C. Desenclos)</div><div class="fm-affl" lang="en" id="aff2">Universit&#x000e9; Paris-Descartes, Paris, France (F. Lanternier, O. Lortholary)</div><div class="fm-affl" lang="en" id="aff3">Institut Pasteur, Paris (E. Dannaoui, F. Dromer, O. Lortholary)</div><div class="fm-affl" lang="en" id="aff4">H&#x000f4;pital Georges Pompidou, Paris (E. Dannaoui).</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140585427131008_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2819884/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140585412721264" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140585412721264title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last">We analyzed hospital records to provide a population-based estimate of zygomycosis incidence and trends over a 10-year period at a national level in France. Data showed an increasing incidence from 0.7/million in 1997 to 1.2/million in 2006 (p&#x0003c;0.001). We compared our data with those from the French Mycosis Study Group, a recently established voluntary network of French mycologists coordinated by the National Reference Center for Mycoses and Antifungals. We documented that incidence of zygomycosis increased, particularly in patients with hematologic malignancies or bone marrow transplants. The role of previous exposure to antifungal drugs lacking activity against zygomycetes could explain this increase but does not appear exclusive. Incidence also increased in the population of patients with diabetes mellitus. We conclude that observed trends reflect a genuine increase of zygomycosis cases in at-risk populations.</p></div><div class="sec"><strong class="kwd-title">Keywords:  </strong><span class="kwd-text">Zygomycosis, fungi, immunocompromised, mucormycosis, France, at-risk patients, research</span></div></div><div id="idm140585428341552" class="tsec sec headless whole_rhythm"><p id="__p3" class="p p-first">Zygomycoses are severe angioinvasive infections caused by common filamentous fungi, the zygomycetes. These ubiquitous opportunistic fungi can cause infections with high lethality in immunocompromised or diabetic patients. Whatever the route of infection (inhalation of airborne spores, ingestion, or direct skin inoculation), the hyphae invade blood vessels, causing tissue infarction and necrosis (<a href="#R1" rid="R1" class=" bibr popnode"><em>1</em></a>&#x02013;<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853313"><em>4</em></a>). In healthy persons, innate immunity is sufficient to prevent infection, except in cases of massive contamination after traumatic inoculation of contaminated soil (<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853315"><em>5</em></a>). Patients with phagocytic dysfunctions caused by neutropenia or ketoacidosis, as well as patients with high iron serum concentrations, are at high risk of developing zygomycosis (<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853323"><em>4</em></a>). These underlying conditions can influence clinical presentation and outcome (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853286"><em>2</em></a>,<a href="#R6" rid="R6" class=" bibr popnode"><em>6</em></a>,<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853329"><em>7</em></a>). The rhinocerebral presentation is the most frequently reported localized symptom followed by pulmonary, cutaneous, cerebral, gastrointestinal, and disseminated infections (<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853320"><em>3</em></a>,<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853285"><em>8</em></a>). In the rhinocerebral or pulmonary forms, patient death rates are reported to be as high as 60% because of delayed diagnosis or delayed therapeutic management (<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853297"><em>7</em></a>&#x02013;<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853298"><em>9</em></a>). Treatment strategies are based on high doses of any lipid formulation of amphotericin B, associated with large surgical resections when possible. Most triazole agents are not effective in vivo (<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853305"><em>10</em></a>), except for posaconazole, which shows some efficacy both experimentally and in patients as second-line therapy (<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853322"><em>11</em></a>&#x02013;<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853306"><em>13</em></a>). The clinical contribution of new iron chelating agents remains controversial (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853294"><em>14</em></a>,<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853326"><em>15</em></a>).</p><p id="__p4" class="p">Some reports have suggested an increasing incidence of zygomycosis on the basis of analysis of data from monocentric studies (<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853331"><em>7</em></a>,<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853291"><em>10</em></a>,<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853302"><em>14</em></a>,<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853314"><em>16</em></a>). Several explanations have been posited: longer survival of persons with severe hematologic malignancies or solid organ transplantations; increased knowledge of the infection and thus a better diagnosis yield; and finally, prolonged use of new antifungal drugs ineffective against zygomycetes as prophylactic or empiric treatment in bone marrow transplant recipients or other immunocompromised patients (<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853296"><em>10</em></a>,<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853319"><em>17</em></a>&#x02013;<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853325"><em>20</em></a>). However, the incidence of infection among the general population and infection trends over time has rarely been documented at a national level. To describe the demographic characteristics of patients and to estimate the incidence and case-fatality ratio (CFR) associated with the major underlying diseases, we analyzed the electronic hospitalization and death records of patients in France in whom zygomycosis had been diagnosed.</p></div><div id="__sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec1title">Material and Methods</h2><div id="__sec2" class="sec sec-first"><h3 id="__sec2title">Data Sources</h3><p id="__p5" class="p p-first">To describe cases and to estimate incidence, we extracted all hospital records related to zygomycosis from 1997 through 2006 in metropolitan France, which includes mainland France and the island of Corsica. The French hospital information system, Programme de M&#x000e9;dicalisation du Syst&#x000e8;me d&#x02019;Information (PMSI), is a managerial tool based on the systematic collection of standardized administrative and medical information for any new hospital admission. An estimated 95% of all public and private hospitals use this tool, including all third-level structures, i.e., university hospitals and other reference hospitals (<a href="#R21" rid="R21" class=" bibr popnode"><em>21</em></a>). An anonymous extraction of the dataset with limited sociodemographic information (age, sex, and residence area) can be made available for specific epidemiologic studies. Medical information includes the main cause of admission (principal diagnosis), the related medical conditions (with &#x0003e;20 entries for various associated diagnoses), duration of stay, modes of admission and discharge, and major medical activities performed during the stay. Diseases are coded according to the International Classification of Diseases, 10th revision (ICD-10). This coding system was stable during the study period. Conversely, the codes for medical or surgical procedures, determined at the national level, have evolved over time, with notable changes occurring in 2003.</p><p id="__p6" class="p p-last">To estimate the overall CFR, deaths that occurred during hospitalization, including those among readmitted patients, were identified through the PMSI<em>.</em> To take into account deaths that occurred after discharge<em>,</em> we also used data from death certificates available at the institution in charge of recording and analyzing death certificates, the CepiDc. The certificate is completed at the time of death by the attending physician (at hospital or home) who records the main cause of death (i.e., the direct, immediate cause), as well as underlying diseases that may have contributed to death. The certificate is then sent to the CepiDc, where it is coded according to ICD-10.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Case Identification</h3><p id="__p7" class="p p-first-last">We used all PMSI records in which the ICD-10 codes B46 or B460 to B469 were identified; these corresponded to any clinical presentation of zygomycosis, or mucormycosis. To distinguish first admissions from rehospitalizations, we created a unique patient identifier by chaining the variables year of birth (derived from the patient&#x02019;s age and the date of admission), gender, and residence postal code. The same identifier was used to match PMSI and CepiDc data, to identify additional deaths and to check for duplicates. However, the CepiDc identifier was based on the exact year of birth, but in the PMSI we derived the year of birth from age at admission.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Case Definitions</h3><p id="__p8" class="p p-first">We defined as unique cases those that had an identifier detected only 1 time in the PMSI during the 10-year period. Cases detected &#x0003e;1 time were classified as new cases at first occurrence in the database; subsequent ones were coded as readmissions. After checking for duplicates, we analyzed unique or new cases for incidence.</p><p id="__p9">The zygomycosis cases were classified according to their clinical presentation, when available. When several body localizations were reported, we selected the most severe one, either in a single stay or in subsequent admissions. For instance, the association of unspecified localization (B46, B468, or B469) or gastrointestinal (B462) or cutaneous (B463) localizations, together with a pulmonary (B461), a rhinocerebral (B462), or a disseminated (B464) localization, was classified under 1 of the 3 latter categories.</p><p id="__p10" class="p p-last">We similarly analyzed the underlying diseases potentially associated with zygomycosis and focused on known risk factors. We combined the ICD-10 codes with medical procedures because some conditions, such as bone marrow transplantation, were coded as a procedure and not as a disease<em>.</em> To take into consideration patients with &#x0003e;1 underlying condition, we introduced a hierarchy. We first created the bone marrow transplantation (BMT) category, which included autologous and allogenic BMT, with or without graft versus host disease. To reduce underreporting bias, we looked for BMT occurrence in both incident and readmitted patients. Because of changes in the coding system regarding medical procedures, identification of autologous versus allogenic BMTs before 2003 was not possible. In a second category labeled hematologic malignancies, we included neutropenia or aplastic anemia, acute lymphoid or myeloid leukemia, lymphomas, and other disorders of the myeloid system. The third category, labeled nonhematologic immunodepression, included solid organ cancers, HIV infection, solid organ transplantations, and/or rejection of these transplantations. By convention, BMT patients (with or without graft versus host disease) who also had a neutropenia were classified under the BMT category. Finally, we analyzed diabetes types 1 or 2 patients under a separate category; for patients who had both an immunosuppressive condition and diabetes, the immunosuppressive condition was kept as the main risk factor.</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Data Analysis</h3><p id="__p11" class="p p-first">Taking into account population growth, we used the 1999 national population census to estimate annual incidence rates. To enable trends comparisons, we used the same approach for the specific incidence rates in patients with underlying factors (zygomycosis patients presenting these underlying factors in the numerator and total population in the denominator). Because of heterogeneous age distributions in the population according to geographic areas, standardization of incidence rates by gender and age groups was performed in each of the 96 districts (departments) of metropolitan France. Populations in the districts ranged from 73,500 to &#x0003e;2.5 million inhabitants.</p><p id="__p12">For CFR, we considered a possible underreporting in the PMSI combined with inaccuracies in the registration of causes of deaths in the CepiDc. To estimate the number of deaths that could have been missed by both data sources, we performed a capture&#x02013;recapture analysis following the method synthesized by Gallay et al. (<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853301"><em>22</em></a>). In a 2 &#x000d7; 2 table, the numbers of deaths identified in one of the respective databases (n<sub>1,2</sub> or n<sub>2,1</sub>, in which the subscript 1 indicates identified and 2 indicates not identified) or in both databases (n<sub>1,1</sub>) are entered in the respective 2 &#x000d7; 2 table&#x02019;s boxes. Under the hypothesis that both sources are independent, deaths that could have been missed by both sources (n<sub>2,2</sub>) can be estimated by the equation (n<sub>2,2</sub> = n<sub>1,2</sub> &#x000d7; n<sub>2,1</sub> / n<sub>1,1</sub>). The total number of deaths is N = n<sub>1,1</sub> + n<sub>1,2</sub> + n<sub>2,1</sub> + n<sub>2,2</sub>. The variance and 95% confidence intervals (CIs) are Var(N) = (n<sub>1,1</sub> + n<sub>2,1</sub>)(n<sub>1,1</sub> + n<sub>1,2</sub>)(n<sub>1,2</sub>)(n<sub>2,1</sub>)/(n<sub>1,1</sub>)<sup>3</sup> and 95% CI = N &#x000b1; 1.96Var(N), respectively.</p><p id="__p13" class="p p-last">The CFR estimates were impaired by the unavailability of accurate information about underlying medical conditions for deaths identified in the CepiDc<em>.</em> In addition, the approximation of the year of birth when using the PMSI dataset limited the CFR studies by age groups. We therefore restricted the analysis to the overall CFR by underlying diseases whenever possible and made no further assumptions on missing data.</p></div><div id="__sec6" class="sec sec-last"><h3 id="__sec6title">Statistical Analysis</h3><p id="__p14" class="p p-first-last">Statistical analysis was performed by using Excel (Microsoft Corporation, Redmond,, WA, USA) and STATA-9 (StataCorp LP, College Station, TX, USA) software. The Fisher exact or &#x003c7;<sup>2</sup> tests were used where appropriate to compare groups. Trends were assessed by using a Poisson regression. Where appropriate, we present results with 95% CIs and p values, considering p<span class="underline">&#x0003c;</span>0.05 as significant.</p></div></div><div id="__sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec7title">Results</h2><div id="__sec8" class="sec sec-first"><h3 id="__sec8title">Increased Incidence of Zygomycosis in Metropolitan France</h3><p id="__p15" class="p p-first">Of 828 hospital stays linked to zygomycosis, 531 incident cases were identified in public and private hospitals of metropolitan France from 1997 through 2006 There were 283 males and 248 females (sex ratio 1.1); mean age was 57.1 years (median 60 years, range: &#x0003c;1 month&#x02013;96 years). The annual incidence rate (AIR) increased from 0.7 cases/million persons in 1997 to 1.2/million persons in 2006 (<a href="/pmc/articles/PMC2819884/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>); yearly increase was +7.4% (p&#x0003c;0.001). Averaged over the 10 years of study, the AIR was 0.9/million persons (95% CI 0.8&#x02013;1.0). This average AIR increased with age from 0.3/million in children aged 0&#x02013;9 years to 3.9/million in patients &#x0003e;89 years of age (<a href="/pmc/articles/PMC2819884/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2819884/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140585409473568" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2819884_09-0334-F1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 09-0334-F1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2819884/bin/09-0334-F1.jpg" /></a></div><div id="largeobj_idm140585409473568" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2819884/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2819884/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p16">Evolution of the incidence of zygomycosis, France, 1997&#x02013;2006. BMT, bone marrow transplantation.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2819884/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140585409470368" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2819884_09-0334-F2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 09-0334-F2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2819884/bin/09-0334-F2.jpg" /></a></div><div id="largeobj_idm140585409470368" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2819884/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2819884/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p17">Average annual incidence rate of zygomycosis, by age group, France, 1997&#x02013;2006. Error bars indicate 95% confidence interval.</p></div></div></div><p id="__p18">The number of patients per district of residence varied from 0 to 36 over the 10-year period. The average standardized incidence rate varied from 0 to 3.4/million persons per district per year. The highest rates were observed in 5 rural districts hosting &#x0003c;500,000 inhabitants each (p&#x0003c;0.01): from 2.4/million (95% CI 2.3&#x02013;2.5) to 3.4/million (95% CI 3.2&#x02013;3.5) versus 0.9/million nationwide. In the greater Paris area hosting &#x02248;10 million inhabitants in 8 districts, the average standardized incidence rate was 1.1/million per year (95% CI 0.9&#x02013;1.2), not significantly different from the rate for the nation.</p><p id="__p19" class="p">Underlying diseases among the 531 zygomycosis case-patients comprised 156 patients with immunosuppressive conditions: 33 patients with BMT, 59 patients with hematologic malignancies, and 64 patients with nonhematologic immunodepression (<a href="/pmc/articles/PMC2819884/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table</span></a>). Of the 104 patients with diabetes, 17 also experienced an underlying immunosuppressive condition and were classified as such. In zygomycosis patients with hematologic malignancies, the specific AIR increased over time from 0.02 to 0.2 cases/million persons from 1997 through 2006 (+24%/year; p&#x0003c;0.001) (<a href="/pmc/articles/PMC2819884/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). It also increased in patients with BMT (+15%/year; p = 0.02) or with diabetes (+9%/year; p = 0.02). Incidence was not significantly altered over time for patients with nonhematologic immunodepression and in patients with no known risk factors (data not shown).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Distribution of zygomycosis cases and deaths, by underlying disease, France, 1997&#x02013;2006</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140585424190320" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Known risk factors</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">No. cases</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">No. deaths</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Case-fatality ratio, %*</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bone marrow transplantation<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">33<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">12<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">36.4<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hematologic malignancies</td><td valign="top" align="center" rowspan="1" colspan="1">59</td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">35.6</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Neutropenia/aplastic anemia</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td valign="top" align="center" rowspan="1" colspan="1">47.8</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Acute lymphoid/myeloid leukemias</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">30.0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Other lymphoid/myeloid disorders<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">16<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">4<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">25.0<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nonhematologic immunodepression</td><td valign="top" align="center" rowspan="1" colspan="1">64</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">12.5</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cancers of the solid organs</td><td valign="top" align="center" rowspan="1" colspan="1">28</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">10.7</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">HIV/AIDS</td><td valign="top" align="center" rowspan="1" colspan="1">26</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">3.8</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Solid organ transplantations<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">10<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">4<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">40.0<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Diabetes<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">86<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">8<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">9.3<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No known risk factor<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">289<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">12<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">4.2<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">531</td><td valign="top" align="center" rowspan="1" colspan="1">61</td><td valign="top" align="center" rowspan="1" colspan="1">11.5</td></tr></tbody></table></div><div id="largeobj_idm140585424190320" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2819884/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p20">*Calculated only for the 61 deaths reported in hospital records for which information about underlying diseases was available.</p></div></div></div><div id="__sec9" class="sec"><h3 id="__sec9title">Clinical Presentation</h3><p id="__p21" class="p p-first-last">The reported presentations included pulmonary (18.5%), rhinocerebral (11.8%), cutaneous (9.4%), and disseminated (6.8%) localizations. The digestive tract was mentioned as a unique localization for 123 (23.2%) patients. No information was available for 30.3% of patients.</p></div><div id="__sec10" class="sec sec-last"><h3 id="__sec10title">Deaths</h3><p id="__p22" class="p p-first-last">Sixty-one deaths were recorded in the PMSI dataset, including 7 deaths reported among readmitted patients. We identified 31 additional deaths in the CepiDc<em>,</em> resulting in a total of 92 deaths during the study period and an overall CFR of 17.3% (95% CI 9.1&#x02013;31.5). Lethality evolved over time and increased from 2004 onward: average CFR was 13.7% in the 1997&#x02013;2003 period versus 23.6% in the 2004&#x02013;2006 period (p&#x0003c;0.01). Using the capture&#x02013;recapture method, the overall expected number of deaths would reach 143 (95% CI 0&#x02013;40) for a CFR of 26.9% (95% CI 0&#x02013;100%). The specific CFR according to underlying conditions was calculated only for the 61 deaths reported in the PMSI for which information was available (<a href="/pmc/articles/PMC2819884/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table</span></a>). It was greater when patients had hematologic malignancies (47.8%) or BMT (36.4%). In patients with nonhematologic immunodepression, diabetes, or no known risk factors, the CFRs were 12.5%, 9.3%, and 4.2%, respectively.</p></div></div><div id="__sec11" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec11title">Discussion</h2><div id="__sec12" class="sec sec-first"><h3 id="__sec12title">Incidence and Trends</h3><p id="__p23" class="p p-first">This retrospective analysis of hospital records provides a population-based estimate of zygomycosis incidence and trends over a 10-year period at a national level. It shows an increasing incidence from 0.7/million to 1.2/million population (p&#x0003c;0.001). The average 0.9/million annual incidence rate in France is lower than the 1.7/million incidence reported in the population-based study by Rees et al. in California in 1992&#x02013;1993 (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853299"><em>23</em></a>). However, our results are based on a passive routine system, whereas an active laboratory-based surveillance was implemented in the San Francisco Bay area at a time of high HIV prevalence; this system had smaller sample sizes (2.9 million in San Francisco vs. &#x02248;60 million in France). In a survey performed in Spain in 2005, incidence was 0.43/10<sup>6</sup> on a representative sample of 50 participating hospitals covering one third of the country&#x02019;s population, i.e., &#x02248;14 million inhabitants (<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853330"><em>24</em></a>).</p><p id="__p24">We compared our data with those from the French Mycosis Study Group, a recently established voluntary network of French mycologists coordinated by the National Reference Center for Mycoses and Antifungals (NRCMA). This network, which covers all university and other tertiary level hospitals in France, reported an average of 17 cases per year since 2003 versus 65 in our study for the same period. These differences could have several nonexclusive reasons. First, diagnosing zygomycosis is not easy. As recently underlined (<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853300"><em>25</em></a>), a culture positive with a zygomycete does not always mean infection; many gastrointestinal cases reported in the PMSI may be false-positive cases resulting from laboratory contamination. The unusual distribution of clinical presentations found in our study and the fact that one third of clinical information was missing favor this hypothesis. Second, we may have overestimated the number of cases because of undetected duplicates or coding errors. However, inversely, underreporting from the voluntary-based NRCMA network may also occur.</p><p id="__p25">The relevance of hospital discharge data based on ICD-10 codes to estimate the incidence of a rare disease is regularly debated because of limitations in diagnosis accuracy, inconsistent disease coding, or undetected duplicates because of anonymous data recording (<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_262321999"><em>26</em></a>)<em>.</em> As reported by Chang et al. (<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853287"><em>27</em></a>), who compared administrative data with medical records in the United States, the positive predictive value of ICD-10 codes for detecting invasive aspergillosis can be low. The authors stressed that these codes may sometimes be assigned before final diagnosis is confirmed, or they may not be assigned by the clinician in charge of the patient. These considerations are also true in the PMSI: overreporting was estimated at 11% for cancers of the thyroid in a study based in 10 districts (<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853284"><em>28</em></a>) and at 15% for mesothelioma (<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853309"><em>29</em></a>). Inversely, underreporting caused by diagnostic or coding errors was estimated at 17% by Hafdi-Nejjari et al. (<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853318"><em>30</em></a>) and at 27% by Carr&#x000e9; et al. (<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853304"><em>28</em></a>), respectively. Nevertheless, administrative data are useful tools to estimate the trends of severe infections like zygomycosis, since most patients are likely to be hospitalized (<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_262322000"><em>26</em></a><em>,</em><a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853316"><em>31</em></a>)<em>,</em> especially in the tertiary care centers that participate in the PMSI.</p><p id="__p26" class="p p-last">We were able to document that the incidence of zygomycosis increased in the population of patients with hematologic malignancies or BMT, as already noticed in the 1990s (<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853303"><em>32</em></a>). In this population, increases in the number of recorded cases could be linked to frequent prescription of antifungal drugs lacking activity against zygomycetes, such as voriconazole and caspofungin (<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853293"><em>10</em></a><em>,</em><a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853308"><em>17</em></a><em>,</em><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324990325"><em>18</em></a><em>,</em><a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853292"><em>33</em></a><em>&#x02013;</em><a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853324"><em>35</em></a>)<em>.</em> However, the role of previous exposure to these antifungal drugs does not appear exclusive because the incidence also increased in the population of patients with diabetes mellitus, a population not known to be commonly exposed to long-term antifungal therapies. An increasing number of the populations at risk (increasing incidence or prolonged survival times) could explain the increase observed in our study: +24% per year for patients with hematologic malignancies and +15% for BMT patients, respectively. However, data from the national agency in charge of the surveillance of transplantations (<a href="#R36" rid="R36" class=" bibr popnode"><em>36</em></a>) indicate that the number of hematopoietic stem cell transplantations increased by +1.58% per year (p&#x0003c;0.01) 2001&#x02013;2006<em>.</em> Similarly, we documented a +9% per year increase in zygomycosis in patients with diabetes; in parallel, diabetes prevalence increased at an estimated 5.7%/year in France from 2000 through 2005 (<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853327"><em>37</em></a>). We thus tend to consider that the observed trends reflect a genuine increase of zygomycosis cases in these at-risk populations.</p></div><div id="__sec13" class="sec"><h3 id="__sec13title">Patients&#x02019; Characteristics</h3><p id="__p27" class="p p-first-last">The PMSI provides scarce information about the sociodemographic characteristics of patients. In a review of 929 cases published from 1940 through 1999, Roden et al. (<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853312"><em>8</em></a>) indicated a 1.8 M:F sex ratio and an average age of 38.8 years, versus 1.1 M:F sex ratio and 57.1 years in our study, respectively. However, age distributions and underlying conditions are likely to differ between places and to evolve over time, thus not allowing strict comparisons. Another limitation of the PMSI is the absence of information regarding the circumstances of exposure and portal of entry. The highest incidence rates found in 5 rural districts and not in others of comparable age and gender distributions may indicate a particular exposure to molds in rural environments (for instance, a professional exposure) or an increased awareness of these diseases among clinicians and microbiologists/mycologists of the corresponding regions.</p></div><div id="__sec14" class="sec sec-last"><h3 id="__sec14title">Patient CFRs</h3><p id="__p28" class="p p-first">Reporting biases may also partially explain the overall low case-fatality ratio in our study: 26.9% in our highest estimate versus 54% in Roden&#x02019;s review of 929 cases (<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853317"><em>8</em></a>). Nevertheless, the CFRs for patients with severe immunosuppressive conditions (<a href="/pmc/articles/PMC2819884/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table</span></a>) are close to values reported in the literature. The CFRs in our study are population-based, while reports from the literature mostly refer to large but relatively old series or to series of immunocompromised patients with severe underlying diseases whose outcome is expected to be worse than in the nonimmunocompromised general population (<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853321"><em>8</em></a>,<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853333"><em>32</em></a>,<a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853328"><em>38</em></a>). Also, the CFRs in these other studies may include the long-term outcomes for more discrete time frames, for example, 1 year survival rates (<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853307"><em>32</em></a>), information not available through our type of study. Deaths occurring during hospitalization are not systematically reported in the PMSI, and those occurring outside the hospital may be underdiagnosed in the CepiDc because many practitioners are not aware of zygomycosis. False-positive cases (for instance, zygomycetes culture without infection) can also influence CFR calculations by increasing the denominator. The wide range of CFR estimates calculated with the capture&#x02013;recapture method reflects these uncertainties.</p><p id="__p29" class="p p-last">Recent progress in early diagnosis and treatment strategies over time should also be considered. For instance, the CFR of rhinocerebral forms may vary from 20% to 69% (<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853288"><em>16</em></a><em>,</em><a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853310"><em>39</em></a>)<em>.</em> Roden et al. showed a decrease of the global CFR from 84% to 47% over time since the 1950s (<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853290"><em>8</em></a>). Antifungal drugs combined with surgical resections play an important role in decreasing lethality for localized infections. The CFR reportedly decreased from 70% in patients treated with antifungal drugs alone down to 14% in patients who receive combined antifungal drugs and surgical treatment (<a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853289"><em>40</em></a>).</p></div></div><div id="__sec15" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec15title">Conclusion</h2><p id="__p30" class="p p-first-last">Given the stable increase of incidence over years especially among patients presenting known risk factors (<a href="/pmc/articles/PMC2819884/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>), we tend to consider that the increasing numbers of zygomycosis cases are likely to reflect the actual temporal trends of zygomycosis infections diagnosed in the French public and private hospitals. Despite the limitations linked to the sources of data we used, this study provides a useful overview of the zygomycosis incidence trends over a decade at a western European country level. It stresses the growing frequency of this severe infection and the need to increase awareness among clinicians of early diagnosis and treatment, especially for patients with hematologic malignancies, BMT, and/or diabetes. As stated by Chang et al. (<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_190853295"><em>27</em></a>), administrative data can be regarded as useful screening tools that should be completed by medical record investigation. In fact, our study has represented an opportunity to launch in 2008 a retrospective study of zygomycosis cases identified through the PMSI and the NRCMA<em>.</em> This study will provide a description of zygomycosis cases and their outcome in France. In addition, it should enable us to evaluate the predictive value of administrative data for this rare disease.</p></div><div id="idm140585496806064" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140585496806064title">Acknowledgments</h2><div class="sec"><p id="__p32">We thank Javier Nicolau and Pascale Bernillon for their support with data extraction and analysis. We also thank Serge Alfandari and Jean Michel Thiolet for their helpful review of the manuscript.</p></div></div><div id="idm140585461338512" class="tsec sec headless whole_rhythm"><h2 class="head no_bottom_margin" id="idm140585461338512title">Biographies</h2><div class="bio"><div class="left">&#x02022;\xc2\xa0</div><p id="__p33" class="p p-first-last">Dr Bitar is a medical epidemiologist at the French Institute for Public Health Surveillance. Her research interests include severe acute respiratory syndrome and other respiratory diseases, as well as the factors contributing to their emergence, such as international travel, climate change, and at-risk populations.</p></div><div class="bio"><div class="left">&#x02022;\xc2\xa0</div><p id="__p34" class="p p-first-last">Address for correspondence: Dounia Bitar, Infectious Diseases Department, Institut de Veille Sanitaire, 94415 Saint Maurice, France; email: d.bitar@invs.sante.fr</p></div> </div><div id="idm140585496808896" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140585496808896title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140585496808768"><p id="__p31" class="p p-first-last"><em>Suggested citation for this article</em>: Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997&#x02013;2006. Emerg Infect Dis [serial on the Internet]. 2009 Sep [<em>date cited</em>]. Available from <a href="http://www.cdc.gov/EID/content/15/9/1395.htm" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.cdc.gov/EID/content/15/9/1395.htm</a></p></p></div></div><div id="idm140585461337312" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140585461337312title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1.  <span class="mixed-citation">Dromer F, Mc Ginnis MR Zygomycosis. In: Anaissie EJ, Mc Ginnis MR, Pfaller MA, editors. Clinical mycology. New York: Churchill Livingstone; 2002.  p. 297&#x02013;308. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Dromer+++F+,++Mc+Ginnis+++MR++Zygomycosis.+In:+Anaissie+EJ,+Mc+Ginnis+MR,+Pfaller+MA,+editors.+Clinical+mycology.+New+York:+Churchill+Livingstone;++2002++p.+297&#x02013;308.+" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2.  <span class="mixed-citation">Greenberg RN, Scott LJ, Vaughn HH, Ribes JA <span class="ref-title">Zygomycosis (mucormycosis): emerging clinical importance and new treatments. </span><span class="ref-journal">Curr Opin Infect Dis</span> 2004;<span class="ref-vol">17</span>:517&#x02013;25 10.1097/00001432-200412000-00003 [<a href="/pubmed/15640705" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00001432-200412000-00003" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Infect+Dis&amp;title=Zygomycosis+(mucormycosis):+emerging+clinical+importance+and+new+treatments.&amp;volume=17&amp;publication_year=2004&amp;pages=517-25&amp;pmid=15640705&amp;doi=10.1097/00001432-200412000-00003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3.  <span class="mixed-citation">Ribes JA, Vanover-Sams CL, Baker DJ <span class="ref-title">Zygomycetes in human disease. </span><span class="ref-journal">Clin Microbiol Rev</span> 2000;<span class="ref-vol">13</span>:236&#x02013;301 10.1128/CMR.13.2.236-301.2000 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC100153/">PMC free article</a>]</span> [<a href="/pubmed/10756000" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FCMR.13.2.236-301.2000" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Microbiol+Rev&amp;title=Zygomycetes+in+human+disease.&amp;volume=13&amp;publication_year=2000&amp;pages=236-301&amp;pmid=10756000&amp;doi=10.1128/CMR.13.2.236-301.2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4.  <span class="mixed-citation">Spellberg B, Edwards J Jr, Ibrahim A <span class="ref-title">Novel perspectives on mucormycosis: pathophysiology, presentation, and management. </span><span class="ref-journal">Clin Microbiol Rev</span> 2005;<span class="ref-vol">18</span>:556&#x02013;69 10.1128/CMR.18.3.556-569.2005 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1195964/">PMC free article</a>]</span> [<a href="/pubmed/16020690" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FCMR.18.3.556-569.2005" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Microbiol+Rev&amp;title=Novel+perspectives+on+mucormycosis:+pathophysiology,+presentation,+and+management.&amp;volume=18&amp;publication_year=2005&amp;pages=556-69&amp;pmid=16020690&amp;doi=10.1128/CMR.18.3.556-569.2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5.  <span class="mixed-citation">Liang KP, Tleyjeh IM, Wilson WR, Roberts GD, Temesgen Z <span class="ref-title">Rhino-orbitocerebral mucormycosis caused by <em>Apophysomyces elegans.</em> </span><span class="ref-journal">J Clin Microbiol</span> 2006;<span class="ref-vol">44</span>:892&#x02013;8 10.1128/JCM.44.3.892-898.2006 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1393113/">PMC free article</a>]</span> [<a href="/pubmed/16517873" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJCM.44.3.892-898.2006" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Rhino-orbitocerebral+mucormycosis+caused+by+Apophysomyces+elegans.&amp;volume=44&amp;publication_year=2006&amp;pages=892-8&amp;pmid=16517873&amp;doi=10.1128/JCM.44.3.892-898.2006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6.  <span class="mixed-citation">Bouza E, Munoz P, Guinea J <span class="ref-title">Mucormycosis: an emerging disease? </span><span class="ref-journal">Clin Microbiol Infect</span> 2006;<span class="ref-vol">12</span>(<span class="ref-iss">Suppl. 7</span>):7&#x02013;23 10.1111/j.1469-0691.2006.01604.x [<a href="//dx.doi.org/10.1111%2Fj.1469-0691.2006.01604.x" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Microbiol+Infect&amp;title=Mucormycosis:+an+emerging+disease?&amp;volume=12&amp;issue=Suppl.+7&amp;publication_year=2006&amp;pages=7-23&amp;doi=10.1111/j.1469-0691.2006.01604.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7.  <span class="mixed-citation">Chayakulkeeree M, Ghannoum MA, Perfect JR <span class="ref-title">Zygomycosis: the re-emerging fungal infection. </span><span class="ref-journal">Eur J Clin Microbiol Infect Dis</span> 2006;<span class="ref-vol">25</span>:215&#x02013;29 10.1007/s10096-006-0107-1 [<a href="/pubmed/16568297" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs10096-006-0107-1" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Clin+Microbiol+Infect+Dis&amp;title=Zygomycosis:+the+re-emerging+fungal+infection.&amp;volume=25&amp;publication_year=2006&amp;pages=215-29&amp;pmid=16568297&amp;doi=10.1007/s10096-006-0107-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8.  <span class="mixed-citation">Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al.<span class="ref-title">Epidemiology and outcome of zygomycosis: a review of 929 reported cases. </span><span class="ref-journal">Clin Infect Dis</span> 2005;<span class="ref-vol">41</span>:634&#x02013;53 10.1086/432579 [<a href="/pubmed/16080086" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F432579" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Epidemiology+and+outcome+of+zygomycosis:+a+review+of+929+reported+cases.&amp;volume=41&amp;publication_year=2005&amp;pages=634-53&amp;pmid=16080086&amp;doi=10.1086/432579&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9.  <span class="mixed-citation">Chamilos G, Lewis RE, Kontoyiannis DP <span class="ref-title">Delaying amphotericin B&#x02013;based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. </span><span class="ref-journal">Clin Infect Dis</span> 2008;<span class="ref-vol">47</span>:503&#x02013;9 10.1086/590004 [<a href="/pubmed/18611163" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F590004" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Delaying+amphotericin+B&#x02013;based+frontline+therapy+significantly+increases+mortality+among+patients+with+hematologic+malignancy+who+have+zygomycosis.&amp;volume=47&amp;publication_year=2008&amp;pages=503-9&amp;pmid=18611163&amp;doi=10.1086/590004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10.  <span class="mixed-citation">Marty FM, Cosimi LA, Baden LR <span class="ref-title">Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. </span><span class="ref-journal">N Engl J Med</span> 2004;<span class="ref-vol">350</span>:950&#x02013;2 10.1056/NEJM200402263500923 [<a href="/pubmed/14985500" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM200402263500923" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Breakthrough+zygomycosis+after+voriconazole+treatment+in+recipients+of+hematopoietic+stem-cell+transplants.&amp;volume=350&amp;publication_year=2004&amp;pages=950-2&amp;pmid=14985500&amp;doi=10.1056/NEJM200402263500923&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11.  <span class="mixed-citation">Dannaoui E, Meis JF, Loebenberg D, Verweij PE <span class="ref-title">Activity of posaconazole in treatment of experimental disseminated zygomycosis. </span><span class="ref-journal">Antimicrob Agents Chemother</span> 2003;<span class="ref-vol">47</span>:3647&#x02013;50 10.1128/AAC.47.11.3647-3650.2003 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC253802/">PMC free article</a>]</span> [<a href="/pubmed/14576138" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FAAC.47.11.3647-3650.2003" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob+Agents+Chemother&amp;title=Activity+of+posaconazole+in+treatment+of+experimental+disseminated+zygomycosis.&amp;volume=47&amp;publication_year=2003&amp;pages=3647-50&amp;pmid=14576138&amp;doi=10.1128/AAC.47.11.3647-3650.2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12.  <span class="mixed-citation">Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, et al.<span class="ref-title">Posaconazole as salvage therapy for zygomycosis. </span><span class="ref-journal">Antimicrob Agents Chemother</span> 2006;<span class="ref-vol">50</span>:126&#x02013;33 10.1128/AAC.50.1.126-133.2006 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1346806/">PMC free article</a>]</span> [<a href="/pubmed/16377677" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FAAC.50.1.126-133.2006" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob+Agents+Chemother&amp;title=Posaconazole+as+salvage+therapy+for+zygomycosis.&amp;volume=50&amp;publication_year=2006&amp;pages=126-33&amp;pmid=16377677&amp;doi=10.1128/AAC.50.1.126-133.2006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13.  <span class="mixed-citation">van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP <span class="ref-title">Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. </span><span class="ref-journal">Clin Infect Dis</span> 2006;<span class="ref-vol">42</span>:e61&#x02013;5 10.1086/500212 [<a href="/pubmed/16511748" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F500212" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Posaconazole+is+effective+as+salvage+therapy+in+zygomycosis:+a+retrospective+summary+of+91+cases.&amp;volume=42&amp;publication_year=2006&amp;pages=e61-5&amp;pmid=16511748&amp;doi=10.1086/500212&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14.  <span class="mixed-citation">Soummer A, Mathonnet A, Scatton O, Massault PP, Paugam A, Lemiale V, et al.<span class="ref-title">Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis. </span><span class="ref-journal">Antimicrob Agents Chemother</span> 2008;<span class="ref-vol">52</span>:1585&#x02013;6 10.1128/AAC.01611-07 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2292512/">PMC free article</a>]</span> [<a href="/pubmed/18212106" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FAAC.01611-07" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob+Agents+Chemother&amp;title=Failure+of+deferasirox,+an+iron+chelator+agent,+combined+with+antifungals+in+a+case+of+severe+zygomycosis.&amp;volume=52&amp;publication_year=2008&amp;pages=1585-6&amp;pmid=18212106&amp;doi=10.1128/AAC.01611-07&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15.  <span class="mixed-citation">Spellberg B, Andes D, Perez M, Anglim A, Bonilla H, Mathisen GE, et al.<span class="ref-title">Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. </span><span class="ref-journal">Antimicrob Agents Chemother</span> 2009;<span class="ref-vol">53</span>:3122&#x02013;5 10.1128/AAC.00361-09 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2704638/">PMC free article</a>]</span> [<a href="/pubmed/19433555" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FAAC.00361-09" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob+Agents+Chemother&amp;title=Safety+and+outcomes+of+open-label+deferasirox+iron+chelation+therapy+for+mucormycosis.&amp;volume=53&amp;publication_year=2009&amp;pages=3122-5&amp;pmid=19433555&amp;doi=10.1128/AAC.00361-09&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16.  <span class="mixed-citation">Prabhu RM, Patel R <span class="ref-title">Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. </span><span class="ref-journal">Clin Microbiol Infect</span> 2004;<span class="ref-vol">10</span>(<span class="ref-iss">Suppl 1</span>):31&#x02013;47 10.1111/j.1470-9465.2004.00843.x [<a href="/pubmed/14748801" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1470-9465.2004.00843.x" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Microbiol+Infect&amp;title=Mucormycosis+and+entomophthoramycosis:+a+review+of+the+clinical+manifestations,+diagnosis+and+treatment.&amp;volume=10&amp;issue=Suppl+1&amp;publication_year=2004&amp;pages=31-47&amp;pmid=14748801&amp;doi=10.1111/j.1470-9465.2004.00843.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17.  <span class="mixed-citation">Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, et al.<span class="ref-title">Zygomycosis in a tertiary-care cancer center in the era of aspergillus-active antifungal therapy: a case&#x02013;control observational study of 27 recent cases. </span><span class="ref-journal">J Infect Dis</span> 2005;<span class="ref-vol">191</span>:1350&#x02013;60 10.1086/428780 [<a href="/pubmed/15776383" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F428780" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Zygomycosis+in+a+tertiary-care+cancer+center+in+the+era+of+aspergillus-active+antifungal+therapy:+a+case&#x02013;control+observational+study+of+27+recent+cases.&amp;volume=191&amp;publication_year=2005&amp;pages=1350-60&amp;pmid=15776383&amp;doi=10.1086/428780&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18.  <span class="mixed-citation">Singh N, Aguadao JM, Bonatti H, Forrest G, Gupta KL, Safdar N, et al.<span class="ref-title">Zygomycosis in solid organ transplant recipients: a prospective, matched case&#x02013;control study to assess risks for disease and outcome. </span><span class="ref-journal">J Infect Dis</span> In press [<a href="/pubmed/19659439" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Zygomycosis+in+solid+organ+transplant+recipients:+a+prospective,+matched+case&#x02013;control+study+to+assess+risks+for+disease+and+outcome.&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19.  <span class="mixed-citation">Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, et al.<span class="ref-title">Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. </span><span class="ref-journal">Clin Infect Dis</span> 2004;<span class="ref-vol">39</span>:584&#x02013;7 10.1086/422723 [<a href="/pubmed/15356827" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F422723" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Invasive+zygomycosis+in+hematopoietic+stem+cell+transplant+recipients+receiving+voriconazole+prophylaxis.&amp;volume=39&amp;publication_year=2004&amp;pages=584-7&amp;pmid=15356827&amp;doi=10.1086/422723&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20.  <span class="mixed-citation">Vigouroux S, Morin O, Moreau P, Mechinaud F, Morineau N, Mahe B, et al.<span class="ref-title">Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. </span><span class="ref-journal">Clin Infect Dis</span> 2005;<span class="ref-vol">40</span>:e35&#x02013;7 10.1086/427752 [<a href="/pubmed/15712069" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F427752" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Zygomycosis+after+prolonged+use+of+voriconazole+in+immunocompromised+patients+with+hematologic+disease:+attention+required.&amp;volume=40&amp;publication_year=2005&amp;pages=e35-7&amp;pmid=15712069&amp;doi=10.1086/427752&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21.  <span class="mixed-citation">Buisson G PMSI- Redressements du programme de m&#x000e9;dicalisation des syst&#x000e8;mes d&#x02019;informations, N&#x000b0;80, March 2005.  S&#x000e9;ries Statistiques&#x02014;DREES 2007 [cited 2008 May 21]. Available from <a href="http://www.sante.gouv.fr/drees/seriestat/seriestat80.htm" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.sante.gouv.fr/drees/seriestat/seriestat80.htm</a></span></div><div class="ref-cit-blk half_rhythm" id="R22">22.  <span class="mixed-citation">Gallay A, Vaillant V, Bouvet P, Grimont P, Desenclos JC <span class="ref-title">How many foodborne outbreaks of <em>Salmonella</em> infection occurred in France in 1995? Application of the capture&#x02013;recapture method to three surveillance systems. </span><span class="ref-journal">Am J Epidemiol</span> 2000;<span class="ref-vol">152</span>:171&#x02013;7 10.1093/aje/152.2.171 [<a href="/pubmed/10909954" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Faje%2F152.2.171" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol&amp;title=How+many+foodborne+outbreaks+of+Salmonella+infection+occurred+in+France+in+1995?+Application+of+the+capture&#x02013;recapture+method+to+three+surveillance+systems.&amp;volume=152&amp;publication_year=2000&amp;pages=171-7&amp;pmid=10909954&amp;doi=10.1093/aje/152.2.171&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23.  <span class="mixed-citation">Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL <span class="ref-title">The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992&#x02013;1993: results of population-based laboratory active surveillance. </span><span class="ref-journal">Clin Infect Dis</span> 1998;<span class="ref-vol">27</span>:1138&#x02013;47 10.1086/514975 [<a href="/pubmed/9827260" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F514975" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=The+epidemiological+features+of+invasive+mycotic+infections+in+the+San+Francisco+Bay+area,+1992&#x02013;1993:+results+of+population-based+laboratory+active+surveillance.&amp;volume=27&amp;publication_year=1998&amp;pages=1138-47&amp;pmid=9827260&amp;doi=10.1086/514975&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24.  <span class="mixed-citation">Torres-Narbona M, Guinea J, Martinez-Alarcon J, Munoz P, Gadea I, Bouza E <span class="ref-title">Impact of zygomycosis on microbiology workload: a survey study in Spain. </span><span class="ref-journal">J Clin Microbiol</span> 2007;<span class="ref-vol">45</span>:2051&#x02013;3 10.1128/JCM.02473-06 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1933097/">PMC free article</a>]</span> [<a href="/pubmed/17392438" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJCM.02473-06" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Impact+of+zygomycosis+on+microbiology+workload:+a+survey+study+in+Spain.&amp;volume=45&amp;publication_year=2007&amp;pages=2051-3&amp;pmid=17392438&amp;doi=10.1128/JCM.02473-06&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25.  <span class="mixed-citation">Torres-Narbona M, Guinea J, Martinez-Alarcon J, Munoz P, Pelaez T, Bouza E <span class="ref-title">Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital. </span><span class="ref-journal">Med Mycol</span> 2008;<span class="ref-vol">46</span>:225&#x02013;30 10.1080/13693780701796973 [<a href="/pubmed/18404550" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1080%2F13693780701796973" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Mycol&amp;title=Workload+and+clinical+significance+of+the+isolation+of+zygomycetes+in+a+tertiary+general+hospital.&amp;volume=46&amp;publication_year=2008&amp;pages=225-30&amp;pmid=18404550&amp;doi=10.1080/13693780701796973&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26.  <span class="mixed-citation">Trevejo RT <span class="ref-title">Acute encephalitis hospitalizations, California, 1990&#x02013;1999: unrecognized arboviral encephalitis? </span><span class="ref-journal">Emerg Infect Dis</span> 2004;<span class="ref-vol">10</span>:1442&#x02013;9 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3320407/">PMC free article</a>]</span> [<a href="/pubmed/15496246" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg+Infect+Dis&amp;title=Acute+encephalitis+hospitalizations,+California,+1990&#x02013;1999:+unrecognized+arboviral+encephalitis?&amp;volume=10&amp;publication_year=2004&amp;pages=1442-9&amp;pmid=15496246&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27.  <span class="mixed-citation">Chang DC, Burwell LA, Lyon GM, Pappas PG, Chiller TM, Wannemuehler KA, et al.<span class="ref-title">Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis. </span><span class="ref-journal">Infect Control Hosp Epidemiol</span> 2008;<span class="ref-vol">29</span>:25&#x02013;30 10.1086/524324 [<a href="/pubmed/18171183" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F524324" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infect+Control+Hosp+Epidemiol&amp;title=Comparison+of+the+use+of+administrative+data+and+an+active+system+for+surveillance+of+invasive+aspergillosis.&amp;volume=29&amp;publication_year=2008&amp;pages=25-30&amp;pmid=18171183&amp;doi=10.1086/524324&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28.  <span class="mixed-citation">Carr&#x000e9; N, Uhry Z, Velten M, Tretarre B, Schvartz C, Molinie F, et al.<span class="ref-title">Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroid cancer (1999&#x02013;2000) </span>[in French] <span class="ref-journal">Rev Epidemiol Sante Publique</span> 2006;<span class="ref-vol">54</span>:367&#x02013;76 10.1016/S0398-7620(06)76731-1 [<a href="/pubmed/17088700" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0398-7620(06)76731-1" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rev+Epidemiol+Sante+Publique&amp;title=Predictive+value+and+sensibility+of+hospital+discharge+system+(PMSI)+compared+to+cancer+registries+for+thyroid+cancer+(1999&#x02013;2000)&amp;volume=54&amp;publication_year=2006&amp;pages=367-76&amp;pmid=17088700&amp;doi=10.1016/S0398-7620(06)76731-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29.  <span class="mixed-citation">Geoffroy-Perez B, Imbernon E, Gilg S <span class="ref-title">I, Goldberg M. Comparison of the French DRG based information system (PMSI) with the National Mesothelioma Surveillance Program database </span>[in French] <span class="ref-journal">Rev Epidemiol Sante Publique</span> 2006;<span class="ref-vol">54</span>:475&#x02013;83 10.1016/S0398-7620(06)76747-5 [<a href="/pubmed/17194979" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0398-7620(06)76747-5" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rev+Epidemiol+Sante+Publique&amp;title=I,+Goldberg+M.+Comparison+of+the+French+DRG+based+information+system+(PMSI)+with+the+National+Mesothelioma+Surveillance+Program+database&amp;volume=54&amp;publication_year=2006&amp;pages=475-83&amp;pmid=17194979&amp;doi=10.1016/S0398-7620(06)76747-5&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30.  <span class="mixed-citation">Hafdi-Nejjari Z, Couris CM, Schott AM, Perrot L, Bourgoin F, Borson-Chazot F, et al.<span class="ref-title">Role of hospital claims databases from care units for estimating thyroid cancer incidence in the Rhone-Alpes region of France. </span>[In French] <span class="ref-journal">Rev Epidemiol Sante Publique</span> 2006;<span class="ref-vol">54</span>:391&#x02013;8 10.1016/S0398-7620(06)76737-2 [<a href="/pubmed/17149160" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0398-7620(06)76737-2" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rev+Epidemiol+Sante+Publique&amp;title=Role+of+hospital+claims+databases+from+care+units+for+estimating+thyroid+cancer+incidence+in+the+Rhone-Alpes+region+of+France.&amp;volume=54&amp;publication_year=2006&amp;pages=391-8&amp;pmid=17149160&amp;doi=10.1016/S0398-7620(06)76737-2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31.  <span class="mixed-citation">Tricco AC, Pham B, Rawson NS <span class="ref-title">Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions. </span><span class="ref-journal">J Clin Epidemiol</span> 2008;<span class="ref-vol">61</span>:192&#x02013;7 10.1016/j.jclinepi.2007.03.009 [<a href="/pubmed/18177793" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jclinepi.2007.03.009" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Epidemiol&amp;title=Manitoba+and+Saskatchewan+administrative+health+care+utilization+databases+are+used+differently+to+answer+epidemiologic+research+questions.&amp;volume=61&amp;publication_year=2008&amp;pages=192-7&amp;pmid=18177793&amp;doi=10.1016/j.jclinepi.2007.03.009&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32.  <span class="mixed-citation">Marr KA, Carter RA, Crippa F, Wald A, Corey L <span class="ref-title">Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. </span><span class="ref-journal">Clin Infect Dis</span> 2002;<span class="ref-vol">34</span>:909&#x02013;17 10.1086/339202 [<a href="/pubmed/11880955" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F339202" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Epidemiology+and+outcome+of+mould+infections+in+hematopoietic+stem+cell+transplant+recipients.&amp;volume=34&amp;publication_year=2002&amp;pages=909-17&amp;pmid=11880955&amp;doi=10.1086/339202&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33.  <span class="mixed-citation">Blin N, Morineau N, Gaillard F, Morin O, Milpied N, Harousseau JL, et al.<span class="ref-title">Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin&#x02019;s lymphoma. </span><span class="ref-journal">Leuk Lymphoma</span> 2004;<span class="ref-vol">45</span>:2161&#x02013;3 10.1080/10428190410001700803 [<a href="/pubmed/15370266" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1080%2F10428190410001700803" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leuk+Lymphoma&amp;title=Disseminated+mucormycosis+associated+with+invasive+pulmonary+aspergillosis+in+a+patient+treated+for+post-transplant+high-grade+non-Hodgkin&#x02019;s+lymphoma.&amp;volume=45&amp;publication_year=2004&amp;pages=2161-3&amp;pmid=15370266&amp;doi=10.1080/10428190410001700803&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34.  <span class="mixed-citation">Girmenia C, Moleti ML, Micozzi A, Iori AP, Barberi W, Foa R, et al.<span class="ref-title">Breakthrough <em>Candida krusei</em> fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation. </span><span class="ref-journal">J Clin Microbiol</span> 2005;<span class="ref-vol">43</span>:5395&#x02013;6 10.1128/JCM.43.10.5395-5396.2005 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1248476/">PMC free article</a>]</span> [<a href="/pubmed/16208029" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJCM.43.10.5395-5396.2005" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Breakthrough+Candida+krusei+fungemia+during+fluconazole+prophylaxis+followed+by+breakthrough+zygomycosis+during+caspofungin+therapy+in+a+patient+with+severe+aplastic+anemia+who+underwent+stem+cell+transplantation.&amp;volume=43&amp;publication_year=2005&amp;pages=5395-6&amp;pmid=16208029&amp;doi=10.1128/JCM.43.10.5395-5396.2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35.  <span class="mixed-citation">Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA <span class="ref-title">Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. </span><span class="ref-journal">Clin Infect Dis</span> 2004;<span class="ref-vol">39</span>:743&#x02013;6 10.1086/423274 [<a href="/pubmed/15356792" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F423274" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Breakthrough+fungal+infections+in+stem+cell+transplant+recipients+receiving+voriconazole.&amp;volume=39&amp;publication_year=2004&amp;pages=743-6&amp;pmid=15356792&amp;doi=10.1086/423274&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36.  <span class="mixed-citation">Agence de la Biomedecine Rapport d&#x02019;activit&#x000e9; de l&#x02019;Agence de la Biomedecine 2007, 234 p. [cited 2009 May 20]. Available from <a href="http://www.agence-biomedecine.fr/uploads/document/rapp-synth2007.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.agence-biomedecine.fr/uploads/document/rapp-synth2007.pdf</a></span></div><div class="ref-cit-blk half_rhythm" id="R37">37.  <span class="mixed-citation">Kusnik-Joinville O, Weill A, Salanave B, Ricordeau P, Allemand H <span class="ref-title">Prevalence and treatment of diabetes in France: trends between 2000 and 2005. </span><span class="ref-journal">Diabetes Metab</span> 2008;<span class="ref-vol">34</span>:266&#x02013;72 10.1016/j.diabet.2008.01.005 [<a href="/pubmed/18524662" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.diabet.2008.01.005" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Metab&amp;title=Prevalence+and+treatment+of+diabetes+in+France:+trends+between+2000+and+2005.&amp;volume=34&amp;publication_year=2008&amp;pages=266-72&amp;pmid=18524662&amp;doi=10.1016/j.diabet.2008.01.005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38.  <span class="mixed-citation">Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, et al.<span class="ref-title">The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. </span><span class="ref-journal">Haematologica</span> 2006;<span class="ref-vol">91</span>:1068&#x02013;75 [<a href="/pubmed/16885047" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=The+epidemiology+of+fungal+infections+in+patients+with+hematologic+malignancies:+the+SEIFEM-2004+study.&amp;volume=91&amp;publication_year=2006&amp;pages=1068-75&amp;pmid=16885047&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39.  <span class="mixed-citation">Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, et al.<span class="ref-title">The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. </span><span class="ref-journal">Med Mycol</span> 2006;<span class="ref-vol">44</span>:335&#x02013;42 10.1080/13693780500464930 [<a href="/pubmed/16772227" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1080%2F13693780500464930" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Mycol&amp;title=The+rising+trend+of+invasive+zygomycosis+in+patients+with+uncontrolled+diabetes+mellitus.&amp;volume=44&amp;publication_year=2006&amp;pages=335-42&amp;pmid=16772227&amp;doi=10.1080/13693780500464930&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40.  <span class="mixed-citation">Perlroth J, Choi B, Spellberg B <span class="ref-title">Nosocomial fungal infections: epidemiology, diagnosis, and treatment. </span><span class="ref-journal">Med Mycol</span> 2007;<span class="ref-vol">45</span>:321&#x02013;46 10.1080/13693780701218689 [<a href="/pubmed/17510856" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1080%2F13693780701218689" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Mycol&amp;title=Nosocomial+fungal+infections:+epidemiology,+diagnosis,+and+treatment.&amp;volume=45&amp;publication_year=2007&amp;pages=321-46&amp;pmid=17510856&amp;doi=10.1080/13693780701218689&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2819884&amp;issue-id=184805&amp;journal-id=782&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Emerging Infectious Diseases</span> are provided here courtesy of <strong>Centers for Disease Control and Prevention</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2819884/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2819884/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2819884/pdf/09-0334_finalR.pdf">PDF (484K)</a></li> | <li><a href="#" data-citationid="PMC2819884" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2819884%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2819884%2F&amp;text=Increasing%20Incidence%20of%20Zygomycosis%20(Mucormycosis)%2C%20France%2C%201997%E2%80%932006"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2819884%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19788806" data-aiid="2819884" data-aid="2819884" data-iid="184805" data-domainid="782" data-domain="eid" data-accid="PMC2819884" data-md5="8c0c7d58dc45dc9b58f5213a0d546c22"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:32:04-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1AEB54E9A342D10000000008960895&amp;ncbi_session=8A1AEB54E9A4A831_2198SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2819884%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=eid&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2819884/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1AEB54E9A4A831_2198SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'